Navigation Links
Schering-Plough Reports Financial Results for 2009 Second Quarter
Date:7/21/2009

----- ----- ----- ------- Income before income taxes 773 502 1,707 864 Income tax expense 102 40 231 89 --- -- --- -- Net income $671 $462 $1,476 $775 ==== ==== ====== ==== Preferred stock dividends 38 38 75 75 -- -- -- -- Net income available to common shareholders $633 $424 $1,401 $700 ==== ==== ====== ==== Diluted earnings per common share 4/ $0.38 $0.26 $0.85 $0.43 ===== ===== ===== ===== Average shares outstanding - common and participating - diluted 4/ 1,658 1,632 1,744 1,635 Note: The Company incurs substantial costs related to the cholesterol joint venture, such as selling, general and administrative costs, that are not reflected in the "Equity income" and are borne by the overall cost structure of Schering-Plough. 1/ Cost of sales for the three months ended June 30, 2009 and 2008 include purchase accounting adjustments of $131 million and $354 million, respectively. For the six months ended June 30, 2009 and 2008, cost of sales includes purchase accounting adjustments of $256 million and $1.0 billion, respectively. 2/ Special, merger and acquisition-related charges relate to the Productivity Transformation Program (PTP) and costs incurred related to the proposed merger with Merck. For the three months ended June 30, 2009 and 2008 these charges were $29 million ($18 million for sev
'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related biology technology :

1. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
2. Schering-Plough Announces Pricing of Senior Notes Offering
3. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
4. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
5. Schering-Plough Completes Acquisition of Organon BioSciences
6. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
9. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
10. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
11. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 11, 2014 /PRNewswire-iReach/ -- Maxim Peptide, a website that ... used solely in scientific experiments, is currently celebrating its ... business, Maxim Peptide, which was created by the founders ... and updated website that now features a special deals ... updated with fascinating articles about peptide research, including a ...
(Date:7/11/2014)... BCC Research ( http://www.bccresearch.com ) reveals in its new ... GLOBAL MARKETS , the global market for digital polymerase ... 2013. This is estimated to grow to $490 billion ... (CAGR) of 28.6%. , New digital PCR technology has ... the broader PCR field. The opportunities presented by this ...
(Date:7/11/2014)...  Researchers have pioneered a revolutionary new way ... called Virtual Finger, allows scientists to move through ... synapses using the flat surface of their computer ... studies orders of magnitude more efficient, saving time, ... many areas of experimental biology. The software and ...
(Date:7/10/2014)... Canada (PRWEB) July 10, 2014 ... present in very low abundance and are often ... challenging and time-consuming. , Join presenters Dr. Rowel ... and Dr. John Anders, Head of Quality at ... spectrometer-based approach that can speed detection and quantitation ...
Breaking Biology Technology:Maxim Peptide Celebrates Second Anniversary Online with an Updated Website and Special Deals Section 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 3Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 2Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 3Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2
... Everyone would like MDs to have the best education ... in the April 4 issue of the journal Academic ... how to incorporate this understanding into real world education, particularly ... tried and true teaching strategies. Now, knowing what is happening ...
... March 30, 2011 Spherix Incorporated (Nasdaq: ... in diabetes, metabolic syndrome and atherosclerosis and provider of ... and pharmaceutical companies – today reported financial results for ... Recent and Upcoming Highlights Pharmaceutical ...
... 30, 2011 EntreMed, Inc. (Nasdaq: ENMD ... treatment of cancer, today reported results for the three ... (Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO) For fiscal year ... for fiscal 2009.  For the year ended December 31, ...
Cached Biology Technology:Brain scientists offer medical educators tips on the neurobiology of learning 2Brain scientists offer medical educators tips on the neurobiology of learning 3Brain scientists offer medical educators tips on the neurobiology of learning 4Brain scientists offer medical educators tips on the neurobiology of learning 5Spherix Announces 2010 Financial Results 2Spherix Announces 2010 Financial Results 3Spherix Announces 2010 Financial Results 4Spherix Announces 2010 Financial Results 5Spherix Announces 2010 Financial Results 6Spherix Announces 2010 Financial Results 7EntreMed Reports Fourth Quarter and Year-End 2010 Financial Results 2EntreMed Reports Fourth Quarter and Year-End 2010 Financial Results 3EntreMed Reports Fourth Quarter and Year-End 2010 Financial Results 4
(Date:7/13/2014)... more effective treatments for cachexia, a profound wasting of ... cancer patients, raising their risk of death, according to ... been tried to reverse the condition, which may cause ... but none have had great success. , Scientists reporting ... Nature , led by Bruce Spiegelman, PhD, demonstrated that ...
(Date:7/11/2014)... for Bone and Mineral Research awarded Michael F. Holick, ... with the 2014 Louis V. Avioli Award. Holick, a ... internationally known for revolutionizing the understanding of vitamin D ... award honors a member of the American Society for ... bone and mineral basic research. It is named for ...
(Date:7/11/2014)... 10, 2014---A team of researchers from The Chinese University ... a gene of wild soybean linked to salt tolerance, ... in saline soil. This study published online in ... novel genomic information for crop improvement. , Soybean is ... and human selection, cultivated soybeans have less genetic diversities ...
Breaking Biology News(10 mins):Antibody halts cancer-related wasting condition 2Antibody halts cancer-related wasting condition 3BUSM's Michael F. Holick receives American Society for Bone and Mineral Research award 2BGI reports a novel gene for salt tolerance found in wild soybean 2
... international team of scientists, led by researchers at the ... crucial missing link in the search for the origin ... missing link is the natural reservoir of the virus, ... southern Cameroon. The findings provide important clues to how ...
... wildly different pathogens ?one that infects vegetables, the other ... to get their disease-causing proteins into the cells of ... State and Northwestern universities report in a study published ... The scientists were surprised to learn that the pathogen ...
... shows motion and door sensors placed in elders' homes ... memory changes that are early signs of dementia. , ... International Conference on Alzheimer's Disease and Related Disorders in ... may be a reliable way of assessing changes in ...
Cached Biology News:UAB researchers confirm HIV-1 originated in wild chimpanzees 2Malaria, potato famine pathogen share surprising trait 2In-home sensors spot dementia signs in elderly 2In-home sensors spot dementia signs in elderly 3
... products ATP-Free using Mo Bio luciferase assay. Mo ... service that will allow you to certify your ... and enable you to deliver them to your ... ATP detection limit is 3.5 x 10-12 /l, ...
... provides a comprehensive microarray service for ... embedded within non-coding RNAs (ncRNAs) using ... probe design, which enables highly sensitive ... RNAs (1). This comprehensive service includes ...
Best pricing for 100mg-1.0g scales. Phosphopeptides are our specialty....
... For knockdown of all human, mouse, ... , Genomewide, predesigned siRNAs for ... , Ready-to-use, convenient matching solutions ... Cost-effective RNAi and downstream ...
Biology Products: